Cargando…

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease

BACKGROUND: The aim of the present study was to compare the quantitative flow responses of regadenoson against adenosine using cardiac (15)O-water PET imaging in patients with suspected or known coronary artery disease (CAD). METHODS: Hyperemic myocardial blood flow (MBF) after adenosine and regaden...

Descripción completa

Detalles Bibliográficos
Autores principales: Kero, Tanja, Saraste, Antti, Lagerqvist, Bo, Sörensen, Jens, Pikkarainen, Essi, Lubberink, Mark, Knuuti, Juhani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873130/
https://www.ncbi.nlm.nih.gov/pubmed/34386859
http://dx.doi.org/10.1007/s12350-021-02731-6
_version_ 1784657397508210688
author Kero, Tanja
Saraste, Antti
Lagerqvist, Bo
Sörensen, Jens
Pikkarainen, Essi
Lubberink, Mark
Knuuti, Juhani
author_facet Kero, Tanja
Saraste, Antti
Lagerqvist, Bo
Sörensen, Jens
Pikkarainen, Essi
Lubberink, Mark
Knuuti, Juhani
author_sort Kero, Tanja
collection PubMed
description BACKGROUND: The aim of the present study was to compare the quantitative flow responses of regadenoson against adenosine using cardiac (15)O-water PET imaging in patients with suspected or known coronary artery disease (CAD). METHODS: Hyperemic myocardial blood flow (MBF) after adenosine and regadenoson was compared using correlation and Bland–Altman analysis in 21 patients who underwent rest and adenosine (15)O-water PET scans followed by rest and regadenoson (15)O-water PET scans. RESULTS: Global mean (± SD) MBF values at rest and stress were 0.92 ± 0.27 and 2.68 ± 0.80 mL·g·min for the adenosine study and 0.95 ± 0.29 and 2.76 ± 0.79 mL·g·min for the regadenoson study (P = 0.55 and P = 0.49). The correlations between global and regional adenosine- and regadenoson-based stress MBF were strong (r = 0.80 and r = 0.77). The biases were small for both global and regional MBF comparisons (0.08 and 0.09 mL·min·g), but the limits of agreement were wide for stress MBF. CONCLUSION: The correlation between regadenoson- and adenosine-induced hyperemic MBF was strong but the agreement was only moderate indicating that established cut-off values for (15)0-water PET should be used cautiously if using regadenoson as vasodilator. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-021-02731-6.
format Online
Article
Text
id pubmed-8873130
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88731302022-03-02 Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease Kero, Tanja Saraste, Antti Lagerqvist, Bo Sörensen, Jens Pikkarainen, Essi Lubberink, Mark Knuuti, Juhani J Nucl Cardiol Original Article BACKGROUND: The aim of the present study was to compare the quantitative flow responses of regadenoson against adenosine using cardiac (15)O-water PET imaging in patients with suspected or known coronary artery disease (CAD). METHODS: Hyperemic myocardial blood flow (MBF) after adenosine and regadenoson was compared using correlation and Bland–Altman analysis in 21 patients who underwent rest and adenosine (15)O-water PET scans followed by rest and regadenoson (15)O-water PET scans. RESULTS: Global mean (± SD) MBF values at rest and stress were 0.92 ± 0.27 and 2.68 ± 0.80 mL·g·min for the adenosine study and 0.95 ± 0.29 and 2.76 ± 0.79 mL·g·min for the regadenoson study (P = 0.55 and P = 0.49). The correlations between global and regional adenosine- and regadenoson-based stress MBF were strong (r = 0.80 and r = 0.77). The biases were small for both global and regional MBF comparisons (0.08 and 0.09 mL·min·g), but the limits of agreement were wide for stress MBF. CONCLUSION: The correlation between regadenoson- and adenosine-induced hyperemic MBF was strong but the agreement was only moderate indicating that established cut-off values for (15)0-water PET should be used cautiously if using regadenoson as vasodilator. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-021-02731-6. Springer International Publishing 2021-08-12 2022 /pmc/articles/PMC8873130/ /pubmed/34386859 http://dx.doi.org/10.1007/s12350-021-02731-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Kero, Tanja
Saraste, Antti
Lagerqvist, Bo
Sörensen, Jens
Pikkarainen, Essi
Lubberink, Mark
Knuuti, Juhani
Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
title Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
title_full Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
title_fullStr Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
title_full_unstemmed Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
title_short Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
title_sort quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873130/
https://www.ncbi.nlm.nih.gov/pubmed/34386859
http://dx.doi.org/10.1007/s12350-021-02731-6
work_keys_str_mv AT kerotanja quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease
AT sarasteantti quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease
AT lagerqvistbo quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease
AT sorensenjens quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease
AT pikkarainenessi quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease
AT lubberinkmark quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease
AT knuutijuhani quantitativemyocardialperfusionresponsetoadenosineandregadenosoninpatientswithsuspectedcoronaryarterydisease